dc.contributor.author | ÇEBİ, CEREN | |
dc.contributor.author | Sahmay, Sezai | |
dc.contributor.author | ÖNCÜL, MAHMUT | |
dc.contributor.author | ÖZÇİVİT, İPEK BETÜL | |
dc.contributor.author | BAŞIBÜYÜK, ZAFER | |
dc.date.accessioned | 2022-07-04T12:31:28Z | |
dc.date.available | 2022-07-04T12:31:28Z | |
dc.identifier.citation | ÖNCÜL M., ÖZÇİVİT İ. B. , BAŞIBÜYÜK Z., ÇEBİ C., Sahmay S., "Anti-Mullerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism", EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.273, ss.54-58, 2022 | |
dc.identifier.issn | 0301-2115 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_20273f92-758c-4c2b-9f45-8cf0fbd46ad5 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/181893 | |
dc.identifier.uri | https://doi.org/10.1016/j.ejogrb.2022.04.016 | |
dc.description.abstract | Objective: To determine the usefulness of Anti-Mullerian Hormone (AMH) and antral follicle count (AFC) as an ovarian reserve marker in hypogonadotropic hypogonadism (HH) patients and to find a limit value for the gonadotropin levels in the diagnosis of HH patients. Study design: It is a retrospective cross-sectional single-center study. One hundred ninety-nine women with HH and 171 healthy controls with no cycle disorders were included into this study. Continuous variables were expressed as mean +/- standard deviation. Statistical comparisons were carried out according to the intention to treat by Student's t-test, Mann-Whitney U test, where appropriate. Receiver operating characteristic curve-ROC was used to represent the sensitivity and specificity pair corresponding to decision threshold of FSH and LH levels in HH diagnosis. P < 0.05 was accepted to be statistically significant. Results: There was not any statistically significant difference between HH and control group regarding the age (23.94 +/- 6.56 vs. 23.92 +/- 3.01, respectively; p = 0.09). Serum AMH levels didn't show statistically significant difference between HH and control group (3.26 +/- 2.61 ng/mL vs. 3.15 +/- 1.46 ng/mL, respectively; p = 0.11). The difference of AFC between HH and control group was statistically significant (6.67 +/- 6.33 vs. 10.91 +/- 2.92, respectively; p < 0.001). Follicle-stimulating hormone (FSH), Luteinizing-hormone (LH) and Estradiol (E2) levels between the groups were found to be significantly different. Area under the receiver operating characteristic curve-ROC for FSH was 0.98 and for LH was 0.96. For the diagnosis of HH, FSH levels lower than 3.05 IU/L (with a sensitivity of 92% and specificity of 94%) and LH levels lower than 1.55 IU/L (with a sensitivity of 91% and specificity of 92%) can be used. Conclusion: In conclusion, serum AMH levels reflect the follicle cohort in HH cases validly with negligible underestimation of ovarian reserve. FSH < 3.05 IU/L and LH < 1.55 IU/L could be used with high sensitivity and specificity for the diagnosis of HH. | |
dc.language.iso | eng | |
dc.subject | Health Sciences | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | ÜREME BİYOLOJİSİ | |
dc.subject | Biyoloji ve Biyokimya | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Biyokimya | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Obstetrics and Gynecology | |
dc.subject | Biochemistry (medical) | |
dc.title | Anti-Mullerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism | |
dc.type | Makale | |
dc.relation.journal | EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü | |
dc.identifier.volume | 273 | |
dc.identifier.startpage | 54 | |
dc.identifier.endpage | 58 | |
dc.contributor.firstauthorID | 3423965 | |